Setting new standards in information exchange for the pharmaceutical and biotech industry
Clinical Trials as a Care Option event will be launched in April 2017
February 6, 2017
The Conference Forum is pleased to announce the launch of Clinical Trials as a Care Option (CRAACO), which will take place on April 4, 2017 in Boston, MA. This half-day event is designed to help bring clinical research closer to patients and patients closer to clinical trials.
“Transforming clinical trials into a care option is arguably the most important change that can be made in bringing patients closer to clinical research,” says Valerie Bowling, Executive Director, The Conference Forum. “Higher rates of clinical trial participation within a health system produce better patient outcomes, lower cost of care and happier patients. Health systems and patients get access to the latest research, while pharma gets access to more patients in need of clinical research options. We are really thrilled to present the first public program that brings clinical trial executives together with hospital system executives to bridge a much needed gap.”
Led by Co-Chairs Jeff James of Wilmington Health and Katherine Vandebelt of Eli Lilly & Company, CRAACO opens with keynote speaker sessions on bridging healthcare to life science and vice versa. Additional discussions cover transitioning from research to care by reviewing data and exploring care pathways to increase research participation within the value-based healthcare system, and using clinical research as a counter measure in conjunction with their Accountable Care Organization to drive towards value.
Further sessions include how value-based health care delivery can improve value for patients by improving processes and reducing costs without sacrificing outcomes, and how life science organizations can create value from data science in ways that are technical and organizational, which aligns incentives and make it easier for physicians to conduct clinical research, improve data quality, and preserve patient safety.
“Patients almost never learn about clinical research from their physicians unless their physicians are directly engaged in clinical trials,” says Katherine Vandebelt. “The value of integrating clinical research into the overall continuum of care is often lost on health care organizations. In this meeting, we address how to bridge the gap and overcome many of the obstacles.”
The CRAACO speaking faculty includes:
Christina Åkerman, MD, President, International Consortium of Health Outcome Measurements (ICHOM)
Meredith Alger, Healthcare Researcher, Program Manager, Harvard Business School
Kenneth Bilger, CEO, Christic Clinic
Jennifer Byrne, Founder, Greater Gift Initiative
William Crowne, Chief Science Officer, Optum Labs
Jeff James, CEO, Wilmington Health
Craig Lipset, Head of Clinical Innovation, R&D, Pfizer
Kenneth Mandl, Director, Computational Health Informatics Program, Boston Children’s Hospital and Professor, Harvard Medical School
Robert Matthews, President and CEO, Medisync
John McConnell, MD, CEO, Wake Forest University Medical Center
Toyin Okanlawon, MD, Senior Researcher, Harvard Business School, Institute for Strategy & Competitiveness
Tom Pike, Former CEO, Quintiles
Kyu Rhee, MD, Chief Health Officer, IBM
Jane Shen, PharmD, Senior Director, Innovation, PMG
Katherine Vandebelt, Global Head, Clinical Innovation, Eli Lilly & Company
To learn more about CRAACO, click here.
About the Conference Forum
The Conference Forum is a research firm and develops specialized events for professionals in the life science and healthcare industries. The company currently offers conferences for R&D leaders, clinical development professionals, biotech executives, VCs, drug delivery specialists, patient advocates and non-profit/government healthcare groups. The Conference Forum’s mission is to create the best content, facilitate the exchange ideas and provide quality networking to help move therapeutics to patients faster. Click here to learn more about The Conference Forum.